Thermogenesis

Thermogenesis

Thermogenesis is the heat the body produces as a side effect of metabolism. It falls into two broad types. Obligatory thermogenesis comes from the basic metabolic work cells need to function. Facultative thermogenesis is switched on in response to things like cold or eating. A special form, non-shivering thermogenesis, happens mainly in brown adipose tissue (BAT). There, uncoupling protein 1 (UCP1) in the mitochondria lets protons leak back across the inner membrane, turning chemical energy straight into heat instead of ATP. This is a meaningful way to raise total energy use without exercise.

Diet-induced thermogenesis, also called the thermic effect of food, accounts for about 10% of daily energy use and depends on the mix of carbohydrate, fat and protein eaten. Beyond these natural forms, using drugs to switch on heat-producing pathways has drawn strong interest as an obesity treatment. Hormones, especially glucagon and catecholamines, are powerful triggers: they speed fat breakdown and directly activate brown and beige fat cells. The discovery that adults still have working brown fat, though in varying amounts, has revived interest in treatments that burn energy as heat for metabolic benefit.

Clinical Relevance to Retatrutide

Retatrutide’s glucagon receptor activity is thought to increase thermogenesis, which would help explain why it produces more weight loss than drugs without glucagon activity. Glucagon signaling drives heat production in the liver through wasteful “futile” metabolic cycles and may also activate brown fat directly. Animal studies of glucagon receptor agonists have shown higher energy use and core body temperature, both signs of more heat production. How much thermogenesis contributes to retatrutide’s weight loss in people has not yet been fully measured, but its glucagon receptor activity offers a plausible way to raise energy use beyond what GLP-1 and GIP receptor activity alone can achieve.